Predicting Parkinson's disease trajectory using clinical and neuroimaging baseline measures
- 7 March 2021
- journal article
- research article
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 85, 44-51
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- National Cancer Institute
- Lyda Hill Foundation
- National Institute on Aging
This publication has 23 references indexed in Scilit:
- Abnormal Spontaneous Brain Activity in Early Parkinson’s Disease With Mild Cognitive Impairment: A Resting-State fMRI StudyFrontiers in Physiology, 2018
- Parkinson’s Disease Biomarkers: Perspective from the NINDS Parkinson’s Disease Biomarkers ProgramBiomarkers in Medicine, 2017
- Different Alterations of Cerebral Regional Homogeneity in Early-Onset and Late-Onset Parkinson's DiseaseFrontiers in Aging Neuroscience, 2016
- Prediction of individual clinical scores in patients with Parkinson's disease using resting-state functional magnetic resonance imagingJournal of the Neurological Sciences, 2016
- Amplitude of Low-frequency Oscillations in Parkinson's DiseaseChinese Medical Journal, 2015
- Priorities in Parkinson's disease researchNature Reviews Drug Discovery, 2011
- Regional homogeneity changes in patients with Parkinson's diseaseHuman Brain Mapping, 2008
- An improved approach to detection of amplitude of low-frequency fluctuation (ALFF) for resting-state fMRI: Fractional ALFFJournal of Neuroscience Methods, 2008
- Regional homogeneity approach to fMRI data analysisNeuroImage, 2004
- Relationship of motor symptoms, intellectual impairment, and depression in Parkinson's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1988